O. P. Veiby

发表

Ability of flt 3 Ligand to Stimulate the In Vitro Growth of Primitive Murine Hematopoietic Progenitors Is Potently and Directly Inhibited by Transforming Growth Factor-/ 3 and Tumor Necrosis Factor-a

O. P. Veiby, 2002 .

The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro.

S. Jacobsen, S. Lyman, L. Rusten, 1996, Blood.

The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors

J. Myklebust, S. Jacobsen, C. Okkenhaug, 1995, The Journal of experimental medicine.

Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro.

S. Jacobsen, O. Borge, O. P. Veiby, 1996, Blood.

Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors

S. E. Jacobsen, C. Pronk, D. Bryder, 2011, The Journal of experimental medicine.

Effects of hTNFα expression in T cells on haematopoiesis in transgenic mice

G. Kollias, H. Prydz, L. Probert, 1999 .

The FLT 3 Ligand Potently and Directly Stimulates the Growth and Expansion of Primitive Murine Bone Marrow Progenitor Cells In Vitro : Synergistic Interactions with Interleukin ( IL ) 11 , ILl 2 , and Other Hematopoietic Growth Factors

O. P. Veiby, Stewart D. Lymanll, 2003 .

Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis.

E. Smeland, D. Goeddel, S. Jacobsen, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells

E. Smeland, S. Jacobsen, O. P. Veiby, 1993, The Journal of experimental medicine.

Chemoresistance: Impact of Nuclear Factor (NF)-κB Inhibition by Small Interfering RNA

M. Read, O. P. Veiby, 2004, Clinical Cancer Research.

Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the NF-B p 65 Subunit

M. Read, O. P. Veiby, 2004 .

Tumor Necrosis Factor-a ( TNF-a ) Potently Enhances In Vitro Macrophage Production From Primitive Murine Hematopoietic Progenitor Cells in Combination With Stem Cell Factor and Interleukin-7 : Novel Stimulatory Role of p 55 TNF Receptors

Frede, O. P. Veiby, I. Mcniece, 2000 .

Transforming growth factor-beta1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells.

I. Dybedal, S. Jacobsen, S. Nagata, 1997, Blood.

Thrombopoietin, a Direct Stimulator of Viability and Multilineage Growth of Primitive Bone Marrow Progenitor Cells

S. Jacobsen, O. Borge, O. P. Veiby, 1996, Stem cells.

Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor. Regulation of c-kit and p53 expression.

S. Jacobsen, C. Dubois, F. Jacobsen, 1995, Journal of immunology.

Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3.

S. Jacobsen, O. Borge, S. Lyman, 1996, Blood.

Bidirectional effect of interleukin-10 on early murine B-cell development: stimulation of flt3-ligand plus interleukin-7-dependent generation of CD19(-) ProB cells from uncommitted bone marrow progenitor cells and growth inhibition of CD19(+) ProB cells.

I. Mårtensson, S. Jacobsen, A. Mårtensson, 1997, Blood.

Novel role of interleukin 7 in myelopoiesis: stimulation of primitive murine hematopoietic progenitor cells

S. Jacobsen, F. Jacobsen, O. P. Veiby, 1993, The Journal of experimental medicine.

Responses of normal and rheumatic human articular chondrocytes cultured under various experimental conditions in agarose.

M. Ostensen, O. P. Veiby, J. Pahle, 1991, Scandinavian journal of rheumatology.

Distinct and direct synergistic effects of IL-1 and IL-6 on proliferation and differentiation of primitive murine hematopoietic progenitor cells in vitro.

S. Jacobsen, E. Lien, C. Okkenhaug, 1994, Experimental hematology.

Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin‐coated extracorporeal circuit

R. Stephens, E. Øvrum, K. Sakariassen, 1996, British journal of haematology.

Tumor necrosis factor-alpha (TNF-alpha) potently enhances in vitro macrophage production from primitive murine hematopoietic progenitor cells in combination with stem cell factor and interleukin-7: novel stimulatory role of p55 TNF receptors.

S. Jacobsen, F. Jacobsen, O. P. Veiby, 1994, Blood.

Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells

S. Jacobsen, A. Minty, P. Ferrara, 1994, The Journal of experimental medicine.

Thymic stromal cells support differentiation of natural killer cells from CD34+ bone marrow cells in vitro

G. Tjønnfjord, T. Egeland, O. P. Veiby, 1995, European journal of haematology.

Clinical Studies Phase I Assessment of New Mechanism-Based Pharmacodynamic Biomarkers for MLN 8054 , a Small-Molecule Inhibitor of Aurora A Kinase

S. Tirrell, K. Venkatakrishnan, J. Tabernero, 2011 .

Amino Acid Sequence Analyses of Non‐AA Proteins from Amyloid Fibrils of Bovine Kidney

K. Sletten, O. P. Veiby, G. Husby, 1992, Scandinavian journal of immunology.

The Effect of Strenuous Exercise, Calorie Deficiency and Sleep Deprivation on White Blood Cells, Plasma Immunoglobulins and Cytokines

A. BØyum, J. Reseland, P. Opstad, 1996, Scandinavian journal of immunology.

The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.

S. Jacobsen, L Cui, S E Jacobsen, 1996, Journal of immunology.

Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells.

H. Rollag, M. Degré, H. Sindre, 1996, Blood.

Functional Differences Between CD 38-and DR-Subfractions of CD 34 ' Bone Marrow Cells

S. Funderud, O. Kaalhus, O. P. Veiby, 2002 .

Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.

E. Smeland, S. Jacobsen, S. Funderud, 1994, Blood.

Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase.

Arijit Chakravarty, Hua Liu, Karthik Venkatakrishnan, 2011, Cancer research.

Haemopoietic progenitor cell differentiation: flow cytometric assessment in bone marrow and thymus

G. Tjønnfjord, L. Mørkrid, T. Egeland, 1995, British journal of haematology.

Transforming Growth Factor-β1 Abrogates Fas-Induced Growth Suppression and Apoptosis of Murine Bone Marrow Progenitor Cells

I. Dybedal, S. Jacobsen, S. Nagata, 1997 .

Stem cell factor and interleukin-7 synergize to enhance early myelopoiesis in vitro.

S. Jacobsen, O. P. Veiby, I. Mcniece, 1994, Blood.

Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis

Tobias Schmelzle, J. Carroll, E. Lightcap, 2007, Proceedings of the National Academy of Sciences.

Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody–Drug Conjugate in Patient-derived Xenografts

Andy Z. X. Zhu, J. Bolleddula, C. Xia, 2020, Molecular Cancer Therapeutics.

Growth factors and hematopoietic stem cells.

H. Snodgrass, O. P. Veiby, A. Mikhail, 1997, Hematology/oncology clinics of North America.

Thrombopoietin promotes adhesion of primitive human hemopoietic cells to fibronectin and vascular cell adhesion molecule-1: role of activation of very late antigen (VLA)-4 and VLA-5.

S. Jacobsen, O. Borge, O. P. Veiby, 1997, Journal of immunology.

TNF-alpha bidirectionally modulates the viability of primitive murine hematopoietic progenitor cells in vitro.

T. Stokke, S. Jacobsen, F. Jacobsen, 1996, Journal of immunology.

Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells.

S. Jacobsen, S. Lyman, O. P. Veiby, 1996, Blood.

Abstracts of oral presentations and posters

O. P. Veiby, D. Løvhaug, P. Bhatnagar, 2005, Annals of Hematology.

Mannuronan Enhances Survival of Lethally Irradiated Mice and Stimulates Murine Haematopoiesis In Vitro

G. Skjåk-Bræk, T. Espevik, Ø. Halaas, 1997, Scandinavian journal of immunology.

Direct synergistic effects of IL-4 and IL-11 on proliferation of primitive hematopoietic progenitor cells.

S. Jacobsen, J. Keller, F. Ruscetti, 1995, Experimental Hematology.

A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo

Julie Zhang, E. Greenfield, D. Bradley, 2018, PloS one.

Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitors.

Yuan Tian, Hongbo Zeng, Mansoureh Rezaei, 2011, Journal of medicinal chemistry.

Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha.

J. Myklebust, S. Jacobsen, C. Okkenhaug, 1996, Blood.

Effects of hTNFalpha expression in T cells on haematopoiesis in transgenic mice.

G. Kollias, H. Prydz, L. Probert, 1999, European journal of haematology.

Abstract B120: TAK-164, a GCC-targeted antibody-drug conjugate (ADC) for the treatment of colorectal cancers and other GI malignancies

J. Bolleddula, C. Xia, T. Keating, 2018 .

Tumor necrosis factor restricts hematopoietic stem cell activity in mice : involvement of two distinct receptors

C. Pronk, D. Bryder, O. P. Veiby, 2011 .

Chemoresistance: Impact of Nuclear Factor (NF)-κB Inhibition by Small Interfering RNA

M. Read, O. P. Veiby, 2004, Clinical Cancer Research.

Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor

N. Parikh, Q. Ye, N. Bhola, 2023, Cancer research communications.